Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Pierre Bedossa

Newcastle AuthorsTitleYearFull text
Professor Arun Sanyal
Professor Pierre Bedossa
Professor Quentin Anstee
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis2024
Professor Pierre Bedossa
Professor Quentin Anstee
A Randomized Controlled Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis2024
Professor Fiona Oakley
Dr Simon Cockell
Dr Olivier Govaere
Professor Ann Daly
Professor Arun Sanyal
et al.		An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)2024
Professor Quentin Anstee
Professor Pierre Bedossa
Cenicriviroc Lacked Efficacy to Treat Liver Fibrosis in Nonalcoholic Steatohepatitis: AURORA Phase III Randomized Study2024
Professor Quentin Anstee
Professor Pierre Bedossa
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis2024
Kristy Wonders
Dr Dina Tiniakos
Professor Pierre Bedossa
Professor Quentin Anstee
Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study2023
Kristy Wonders
Dr Dina Tiniakos
Professor Pierre Bedossa
Professor Cliff Brass
Professor Quentin Anstee
Machine learning algorithm improves detection of NASH (NAS-based) and at-risk NASH: a development and validation study2023
Dr Katherine Johnson
Dr Peter Leary
Dr Olivier Govaere
Dr Matthew Barter
Sarah Charlton
et al.		Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance2022
Professor Alastair Burt
Professor Pierre Bedossa
Dr Dina Tiniakos
Fifty years of impact on liver pathology: a history of the Gnomes2021
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Pierre Bedossa
Dr Simon Cockell
Dr Massimo Younes
et al.		NASH limits anti-tumor surveillance in immunotherapy-treated HCC2021
Professor Pierre Bedossa
Professor Quentin Anstee
Professor Arun Sanyal
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study2020
Professor Pierre Bedossa
Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease2020
Professor Quentin Anstee
Professor Pierre Bedossa
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study2020
Professor Quentin Anstee
Dr Rebecca Darlay
Dr Simon Cockell
Dr Olivier Govaere
Dr Dina Tiniakos
et al.		Genome-Wide Association Study of Non-Alcoholic Fatty Liver and Steatohepatitis in a Histologically-Characterised Cohort2020
Dr Timothy Hardy
Kristy Wonders
Dr Massimo Younes
Professor Pierre Bedossa
Entesar Betelmal
et al.		The European NAFLD Registry: a real-world longitudinal cohort study of nonalcoholic fatty liver disease2020
12